Br Med J (Clin Res Ed)  1986;293:1137-1140 (1 November), doi:10.1136/bmj.293.6555.1137

Fate in intermittent claudication: outcome and risk factors.

R Jelnes, O Gaardsting, K Hougaard Jensen, N Baekgaard, K H Tønnesen, T Schroeder

The fate of 257 consecutive patients (100 women) aged 36-85 years (mean 65) first seen with intermittent claudication in 1977 was analysed after a mean of 6.5 (SD 0.5) years. When first seen none of the patients complained of rest pain or had ulcers or gangrenous lesions on the feet. At follow up 113 of the patients (44%) had died. Causes of death were no different from those in the general population. Mortality was twice that of the general population matched for age and sex. Mortality among the men was twice that among the women. In men under 60 mortality was four times that expected. The rate of clinical progression of the arteriosclerotic disease (that is, rest pain or gangrene) of the worst affected leg was 7.5% in the first year after referral. Thereafter the rate was 2.2% a year. An ankle systolic blood pressure below 70 mm Hg, a toe systolic blood pressure below 40 mm Hg, or an ankle/arm pressure index below 50% were individually significantly associated with progression of the arteriosclerotic disease. These findings show the importance of peripheral blood pressure measurements in the management of patients with intermittent claudication due to arteriosclerotic disease.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Sobel, M., Verhaeghe, R. (2008). Antithrombotic Therapy for Peripheral Artery Occlusive Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 815S-843S [Abstract] [Full text]  
  • Poredos, P., Jug, B. (2007). The Prevalence of Peripheral Arterial Disease in High Risk Subjects and Coronary or Cerebrovascular Patients. ANGIOLOGY 58: 309-315 [Abstract]  
  • Badger, S. A., Soong, C. V., O'Donnell, M. E., Boreham, C. A.G., McGuigan, K. E. (2007). Benefits of a Supervised Exercise Program After Lower Limb Bypass Surgery. VASC ENDOVASCULAR SURG 41: 27-32 [Abstract]  
  • Golomb, B. A., Dang, T. T., Criqui, M. H. (2006). Peripheral Arterial Disease: Morbidity and Mortality Implications. Circulation 114: 688-699 [Full text]  
  • Khan, N. A., Rahim, S. A., Anand, S. S., Simel, D. L., Panju, A. (2006). Does the Clinical Examination Predict Lower Extremity Peripheral Arterial Disease?. JAMA 295: 536-546 [Abstract] [Full text]  
  • Clagett, G. P., Sobel, M., Jackson, M. R., Lip, G. Y. H., Tangelder, M., Verhaeghe, R. (2004). Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 609S-626S [Abstract] [Full text]  
  • Missouris, C. G, Kalaitzidis, R. G, Kerry, S. M, Cappuccio, F. P (2004). Predictors of mortality in patients with peripheral vascular disease. A prospective follow-up study. British Journal of Diabetes & Vascular Disease 4: 196-200 [Abstract]  
  • Ostergren, J., Sleight, P., Dagenais, G., Danisa, K., Bosch, J., Qilong, Y., Yusuf, S., for the HOPE study investigators, (2004). Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 25: 17-24 [Abstract] [Full text]  
  • Komarov, A.L., Panchenko, E.P., Dobrovolsky, A.B., Karpov, Yu.A., Deev, A.D., Titaeva, E.V., Davletov, K.K., Eshkeeva, A.R., Markova, L.A. (2002). D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease. Eur Heart J 23: 1309-1316 [Abstract]  
  • Hooi, J. D., Stoffers, H. E.J.H., Kester, A. D. M., van Ree, J. W., Knottnerus, J. A. (2002). Peripheral Arterial Occlusive Disease: Prognostic Value of Signs, Symptoms, and the Ankle-Brachial Pressure Index. Med Decis Making 22: 99-107 [Abstract]  
  • Asgeirsdottir, L. P., Agnarsson, U., Jonsson, G. S. (2001). Lower Extremity Blood Flow in Healthy Men: Effect of Smoking, Cholesterol, and Physical Activity -- A Doppler Study. ANGIOLOGY 52: 437-445 [Abstract]  
  • Hirsch, A. T, Halverson, S. L, Treat-Jacobson, D., Hotvedt, P. S, Lunzer, M. M, Krook, S., Rajala, S., Hunninghake, D. B (2001). The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care. Vasc Med 6: 87-96 [Abstract]  
  • Krug, R. T., Calligaro, K. D., Dougherty, M. J. (2000). Claudication in the Young Patient. PERSPECT VASC SURG ENDOVASC THER 13: 27-38 [Abstract]  
  • Bird, C. E, Criqui, M. H, Fronek, A., Denenberg, J. O, Klauber, M. R, Langer, R. D (1999). Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med 4: 15-21 [Abstract]  
  • Martone, V. D., Perna, S., Cacciatore, F., Corrado, S., Di Donato, A., Di Iorio, A., Brevetti, G. (1998). Intermittent Claudication and Risk of Cardiovascular Events. ANGIOLOGY 49: 843-848 [Abstract]  
  • Criqui, M. H, Denenberg, J. O (1998). The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med 3: 241-245 [Abstract]  
  • Banga, J. D. (1998). Invited Review. VASC ENDOVASCULAR SURG 32: 245-247  
  • Catalano, M., Perilli, E., Carzaniga, G., Scandale, G., Carotta, M. (1997). Arterial Damage, Triglycerides, Apolipoprotein, and Lp-(a) Values in PVD Patients. CLIN APPL THROMB HEMOST 3: 104-109 [Abstract]  
  • Cimminiello, C., Arpaia, G., Aloisio, M., Uberti, T., Rossi, F., Pozzi, F., Bonfardeci, G. (1994). Platelet-Derived Growth Factor (PDGF) in Patients with Different Degrees of Chronic Arterial Obstructive Disease. ANGIOLOGY 45: 289-293 [Abstract]  
  • Neirotti, M., Molaschi, M., Ponzetto, M., Macchione, C., Poli, L., Bonino, F., Fabris, F. (1994). Hemodynamic, Hemorheologic, and Hemocoagulative Changes After Treatment With Picotamide in Patients Affected by Peripheral Arterial Disease (PAD) of the Lower Limbs. ANGIOLOGY 45: 137-141 [Abstract]  
  • Vogt, M. T., Cauley, J. A., Newman, A. B., Kuller, L. H., Hulley, S. B. (1993). Decreased Ankle/Arm Blood Pressure Index and Mortality in Elderly Women. JAMA 270: 465-469 [Abstract]  
  • Esato, K., Zemp, N., Fujioka, K., Ohara, M. (1992). Elective Arterial Reconstruction for Intermittent Claudication is Justified. VASC ENDOVASCULAR SURG 26: 42-46 [Abstract]  
  • Andersson, A. P., Ellitsgaard, N., Jorgensen, B., Fallentin, E., Kollerup, G. B., Holtveg, H., Holstein, P. (1991). Screening for Abdominal Aortic Aneurysm in 295 Outpatients with Intermittent Claudication. VASC ENDOVASCULAR SURG 25: 516-520 [Abstract]  
  • Clagett, G. P. (1990). Antithrombotic Drugs and Vascular Surgery. PERSPECT VASC SURG ENDOVASC THER 3: 79-102  
  • Rosenbloom, M. S., Flanigan, D. P., Schuler, J. J., Meyer, J. P., Durham, J. R., Eldrup-Jorgensen, J., Schwarcz, T. H. (1988). Risk Factors Affecting the Natural History of Intermittent Claudication. Arch Surg 123: 867-870 [Abstract]  
  • Arcan, J.C., Blanchard, J., Boissel, J.P., Destors, J.M., Panak, E. (1988). Multicenter Double-Blind Study of Ticlopidine in the Treatment of Intermittent Claudication and the Prevention of its Complications. ANGIOLOGY 39: 802-811 [Abstract]  
Access jobs at BMJ Careers
Whats new online at Student BMJ